Health
Pfizer, BioNTech Shares Ripe for a Bumpy Ride Ahead of Key Panel – BloombergQuint
Pfizer, BioNTech Shares Ripe for a Bumpy Ride Ahead of Key Panel
(Bloomberg) — Its been a wild ride for Pfizer Inc. shares as the S&P 500 heavyweight got caught up in the vaccine-stock euphoria. A key panel next week could mean even more volatility.
A Food and Drug Administration advisory committee meeting scheduled for Dec. 10 is believed to be a means for the agency to assure the public about Covid-19 vaccine safety, and a U.S. emergency use authorization could follow within days.
Pfizer shares have gained about 20% since late October even after a dip on Thursday,…
-
General22 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News22 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News24 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland